Fujifilm phases out U.S. medical film production
The company anticipates that the phase-out will be completed by April 1.
Fujifilm said that “over the past decade, the medical imaging industry has been undergoing a steady transition from the use of medical imaging film including double and single emulsion and dry films to digital image acquisition and softcopy diagnosis via PACS…Although Fujifilm has been producing x-ray film products, the market shift to PACS systems has led to significant declines in the overall sales of medical film. As a result, Fujifilm Corporation has decided to consolidate the production of all medical film to one facility in Japan.”
Makoto Kawaguchi, Fujifilm Medical Systems USA president and CEO, said “Fujifilm is committed to the quality and innovation of our extensive medical film lines. The ongoing and stable delivery of film to our medical customers will continue without interruption.”